Risk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients

By Kapadia Samir   Hapani Sanjaykumar   Choueiri Toni K.   Wu Shenhong  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1202-1212

Informa Healthcare

Access to resources Recommend Favorite

Urinary Isothiocyanates Level and Liver Cancer Risk: A Nested Case-Control Study in Shanghai, China

By Wu Qi-Jun   Wang Jing   Gao Jing   Zhang Wei   Han Li-Hua   Gao Shan   Gao Yu-Tang   Ji Bu-Tian   Zheng Wei   Shu Xiao-Ou   Xiang Yong-Bing  

Nutrition and Cancer, Vol. 66, Iss. 6, 2014-08 ,pp. : 1023-1029

Routledge Ltd

Access to resources Recommend Favorite

Circulating TGF‐β1 and VEGF and risk of cancer among liver transplant recipients

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1252-1257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Laparoscopic liver resection for cancer

By Nguyen Kevin Tri   Gamblin T Clark   Geller David A  

Future Oncology, Vol. 4, Iss. 5, 2008-10 ,pp. : 661-670

Future Medicine

Access to resources Recommend Favorite

SBRT for Liver Cancer

By  

Current Cancer Therapy Reviews, Vol. 14, Iss. 1, 2018-02 ,pp. : 6-30

Bentham Science Publishers

Access to resources Recommend Favorite